User-friendliness of a Portable Driving Simulator
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT Number: NCT03731299
The aim of this systematic review was to determine the number of muscle synergies and the distribution of muscle weightings in stroke patients during gait.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
The aim of this systematic review was to determine the number of muscle synergies and the distribution of muscle weightings in stroke patients during gait. Although literature has suggested that merging of synergies occurs after stroke and that a larger number of is associated with increased motor function if compared with healthy adults. IIt is still unknown if this hypothesis is also relevant when comparing different functional levels within a stroke population and what functional impact of altered synergies on walking behavior is.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Stroke:
Exclusion criteria
Stroke:
Time frame: Once, in the week of inclusion
Spatial characteristic of muscle synergy compared to healthy adults: the amount of synergies during walking in stroke subjects, the amount of muscles in one synergie and which muscles in one synergy
Time frame: Once, in the week of inclusion
Temporal characteristic of muscle synergy compared to healthy adults: When are these synergies active during the gait cycle (100%).
Universiteit Antwerpen
Other
Are Spatial and Temporal Muscle Synergy Modules Related to Functional Ability After Stroke?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT04685408
Brain Diseases, Cardiovascular Diseases
Kampala, Uganda
View Trial DetailsNCT05016531
Brain Diseases, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07751224
Brain Diseases, Cardiovascular Diseases
Ho Chi Minh City, Vietnam
View Trial Details